Stenhouse Mark 4
4 · Prometheus Biosciences, Inc. · Filed Nov 16, 2021
Insider Transaction Report
Form 4
Stenhouse Mark
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-11-14+70,371→ 70,371 totalExercise: $36.32Exp: 2031-11-13→ Common Stock (70,371 underlying)
Footnotes (1)
- [F1]25% of the shares subject to the option will vest on November 14, 2022, and 1/48th of the shares subject to the option will vest monthly thereafter, subject to the Reporting Person's continued service with the Issuer through each vest date.